CD34 and Menkes disease: The pegGLP-1 treatment increased the number of bone marrow CD45−CD31+CD34+ EPC and precursors of angiogenesis in mice of groups f6 and m6 compared to untreated mice in terms of MD and lung emphysema (Figure 7c).